A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.
about
New insights on premature ejaculation: a review of definition, classification, prevalence and treatmentClinical Practice Guidelines for Management of Sexual Dysfunction.Impact of Antidepressant Drugs on Sexual Function and Satisfaction.Premature ejaculation: do we have effective therapy?The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management.
P2860
A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.
@ast
A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.
@en
type
label
A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.
@ast
A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.
@en
prefLabel
A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.
@ast
A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.
@en
P2860
P1433
P1476
A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.
@en
P2093
Kate Hutchinson
Kelly Cruickshank
P2860
P304
P356
10.2165/11598150-000000000-00000
P50
P577
2012-05-01T00:00:00Z
P5875
P6179
1025923482